Come up with a name for your new list and we'll add to it:
Apeiron Biologics raised a round of funding on August 28, 2017. Investors include
European Investment Bank.
Apeiron is a private biotech company based in Vienna, Austria, engaged in innovative projects in immuno-oncology. Recently the most advanced project (immunotherapy of neuroblastoma) was granted market…